Spring Peach Dao
Release time:
2023-04-03
After several drizzly rains, the spring breeze took away the residual cold of the earth. Peach trees on the bog mountain, like receiving some information, rushed to sprout tender buds and bathed in the long-lost warm sun.
is another March of the year. Tens of thousands of mu of peach blossoms are blooming like intoxicated clouds outside the mountains of Marsh Mountain Village, Baoan Town, Daye. Walking among them, the boundless deep and shallow pink makes people forget to return. "Huang Shi tower front river water east, spring lazy sleepy leaning breeze. Peach blossom a cluster open without owner, lovely deep red love light red?". In his later years, when Du Fu wrote this peach blossom poem, he was in Chengdu. The spring he saw under the Huang Shi Pagoda might be better than the peach blossom garden in front of him?
From a distance, the whole green mountain was dressed in pink and tender new clothes and danced happily under the breeze. Careful observation in the peach blossom forest shows that the peach blossoms on the branches are in different shapes, some are in bud, like a shy girl. Some only bloom two or three petals, such as a butterfly spreading its wings to fly, anxiously showing their graceful posture. The peach blossom in full bloom is like a girl's charming smiling face, sweet and lovely, intoxicating. And those peach blossoms that have already opened, the petals have fallen to the ground, converged into a sea of pink and white flowers, reluctantly spread out around the peach trees ......
3# July 15 this day, the much-anticipated Peach Blossom Festival in the warm sun, the spring breeze as scheduled held. This is already the tenth Peach Blossom Festival successfully held in Marsh Mountain Village. Tourists from all over the world gather to enjoy the beauty of the natural gifts of this world. "Look at a tree of peach blossoms and laugh at people alone", which may be the charm of marshland peach blossoms.
Come on, in this spring when peach blossoms are in full bloom, find a leisurely weekend and ask one or two close friends to stroll through the peach forest together and meet the most beautiful spring of security guards. (Yang Ling)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31